Limerick BioPharma Report issue

For profit Phase 1 Phase 2
Founded: South San Francisco CA United States (2004)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2010
NCT01060475
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

lim-0705 (3 trials)

Drugs in Phase 1 Trials (1)

tacrolimus (prograf) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glucose Intolerance (Phase 2)

Insulin Resistance (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2